Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Milestone Pharmaceuticals Inc.”

9 pharma patents match "Milestone Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "Milestone Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “Milestone Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 12257224

    Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker

    Milestone Pharmaceuticals Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted

  2. US 10117848

    Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  3. US 10010523

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  4. US 10010524

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  5. US 10010522

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  6. US 9737503

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  7. US 9463179

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  8. US 9227918

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  9. US 8501727

    Short acting benzothiazepine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.